Abstract
Aim: Familial hypercholesterolemia (FH) is an autosomal dominant disorder of lipoprotein metabolism mainly caused by LDLR mutations. This study was aimed to assess the different response to lipid-lowering therapy according to LDL receptor phenotype in Italian patients with heterozygous FH.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have